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INTRODUCTION 
Transdermal drug delivery systems, known as patches, 
are dosage forms designed to deliver a therapeutically 
effective amount of drug across a patient’s skin in a 
predetermined time and controlled rate1, 2. There are 
three critical considerations in the selection of a 
transdermal drug delivery system: adhesion to skin, 
compatibility with skin, and physical or chemical 
stability of total formulation and components3. The 
choice and design of polymers, adhesives, penetration 
enhancers and plasticizers in transdermal patches are also 
critical because they have a strong effect on drug release, 
permeability, stability, elasticity, and wearing properties 
of transdermal drug delivery systems4. The use of 
plasticizers in transdermal drug delivery systems are the 
improvement of film forming properties and the 
appearance of the film, decreasing the glass transition 
temperature of the polymer, preventing film cracking, 
increasing film flexibility and obtaining desirable 
mechanical properties5. Plasticizers are low molecular 
weight resins or liquids, which cause a reduction in 
polymerpolymer chain secondary bonding, forming 
secondary bonds with the polymer chains instead6. The 
main reasons of adding plasticizers to polymers, 
improving flexibility and process ability are counted7,8. 
By adding plasticizer to a polymeric material, elongation 
at break, toughness and flexibility are expected to 
increase, on the other hand tensile stress, hardness, are 
expected to decrease9. 
In the present study drug free patches of different 
polymers were formulated and evaluated. The effect of 
different concentrations of plasticizer viz. 10%, 15%, 
20& and 25% on physicochemical properties of drug free 
patches was also studied. 
MATERIAL AND METHOD 
Di-n-butylphthalate (Loba Chemie), chloroform, 
methanol (S. D. Fine Chem. Ltd.), Ethyl cellulose 
(Kemphasol Ltd.). Poly vinyl pyrrolidone (Wockhardt 
Ltd.), aluminum foil purchased from local market. All 
other chemicals used were of analytical grade. 
The drug free transdermal patch was fabricated by 
solvent evaporation technique using Mercury substrate 
method. The different polymers were weighed in same 
ratios and dissolve in 5 ml of solvents. The plasticizer 
(Di-n-butylphthalate) was added at different 
concentration and stirred to get clear solution. The 
polymeric solution was then poured slowly into a glass 
ring on the mercury surface. The solvent was allowed to 
evaporate at 250C for 24 h. The films were stored in 
desiccator until further evaluation. The composition of 
drug free transdermal patches is shown in Table 1. 
Evaluation of the films/patches 
The fabricated patch was subjected to physicochemical 
evaluation by using following tests. 
Folding Endurance 
The folding endurance is defined as the number of folds 
required to break any polymeric patch10.  This was 
performed as a primary test to asses the strength and 
flexibility of film. This was determined by repeatedly 
folding the film at the same place until it broke. The 
number of time the film could be folded at the same 
place without breaking/cracking was taken as value of 
folding endurance11,12. 
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Table 1: Formulation of drug free transdermal patches 
Class of ingredients Ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 
Plasticizer (mg) Di-n-butylphthalate 10 10 10 15 15 15 20 20 20 25 25 25 
Solvents 
(ml) 
Chloroform 4 4 4 4 4 4 4 4 4 4 4 4 
Methanol 1 1 1 1 1 1 1 1 1 1 1 1 
Polymers 
Ratio 
(1:1) 
ERS-100 -- 1 -- -- 1 -- -- 1 -- -- 1 -- 
Poly vinyl pyrrolidone 1 -- 1 1 -- 1 1 -- 1 1 -- 1 
Ethyl cellulose -- -- 1 -- -- 1 -- -- 1 -- -- 1 
ERL-100 1 1 -- 1 1 -- 1 1 -- 1 1 -- 
 
Flatness 
Longitudinal strips were cut out from the prepared 
medicated patches and the length of each strip was 
measured and then the variation in the lengths due to the 
non-uniformity in flatness was measured. Flatness was 
calculated by measuring constriction of strips and a zero 
percent constriction was considered to be equal to a 
hundred percent flatness. 
Constriction (%) = (L1-L2)/L1 × 100, 
Where L1 and L2 are the initial length and final length of 
each strip respectively13,14  
Moisture content 
The film was weighed and kept in a desiccator 
containing calcium chloride at 400C for at least 24 h. The 
percentage moisture content was calculated as the 
difference between initial weight and final constant 
weight and reported with respect to the initial weight15. 
Moisture Uptake 
The films were weighed accurately and placed in 
desiccator containing 100 ml saturated solution of 
aluminum chloride, which maintains 79.5% RH. After 3 
days, the films were taken out and weighed. The 
percentage moisture uptake was calculated as difference 
between final and initial weight with respect to initial 
weight14. 
Water vapor transmission rate (WVTR)  
Glass vials of equal diameter used as transmission cells. 
These transmission cells were washed thoroughly and 
dried in an oven. About 1 gm of anhydrous calcium 
chloride was placed in the cells and respective polymer 
film was fixed over the brim. The cells were accurately 
weighed and kept in a closed desiccator containing 
saturated solution of potassium chloride to maintain RH 
84%. The cells were taken out and weighed after 6, 12, 
24, 36, 48 and 72 h of storage. The amount of water 
vapor transmitted was calculated by using following 
formula and expressed as the number of grams of 
moisture gained/h/cm2. 
Water vapor transmission rate 
 =    final weight – initial weight 
                                Time × Area 
Tensile strength 
Mechanical properties of the polymeric patches were 
conveniently determined by measuring their tensile 
strength16. The tensile strength of the patches was 
determined by using a tensile strength instrument. 
Tensile strength is the maximum stress applied to a point 
at which the specimen breaks, and can be computed from 
the applied load at rupture and the elongation of the 
patch as described from the following equation.  
T.S. = Break Force/ a. b (1+ΔL/L)  
Where a, b and L are width, thickness and length of the 
strip respectively.  
ΔL is the elongation of patch at break point.  
Break force = Weight required to break the patch (Kg.)17  
Tensile strength was calculated as the weight required 
for breaking the film (kg/cm2).   
Percent elongation 
It was calculated from the elongation (length) at the 
moment of rupture of the film divided by the initial 
gauge length of the film and multiplying by 100. An 
instrument and procedure was similar to that used for 
tensile strength18. 
Percent elongation at break = Lb - Lo/ Lo X 100 
Lb = Length of the specimen in cm where it breaks.  
            Lo = Original length of specimen.
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Table 2: Evaluation of drug free transdermal patches 
Group/ 
Formulations 
Folding 
Endurance 
Water vapor  
transmission rate 
(gm/h/cm
2
× 10
-4
) 
Tensile  
Strength 
(kg/cm
2
) 
Percent  
Elongation 
Flatness 
Group-A 
F-1 06 Folds 3.70 2.2 11 %    100 % 
F-2 10 Folds 3.40 3.5 13 % 100 % 
F-3 08 Folds 2.25 2.8 10 % 100 % 
Group-B 
F-4 09 Folds 4.00 3.1 14 % 100 % 
F-5 13 Folds 3.60 4.2 15 % 100 % 
F-6 10 Folds 2.40 3.2 12 % 100 % 
Group-C 
F-7 13 Folds 4.3 4.5 20 % 100 % 
F-8 18 Folds 3.87 5.8 26 % 100 % 
F-9 12 Folds 2.60 4.1 15 % 100 % 
Group-D 
F-10  20 Folds No No No 100 % 
F-11  21 Folds No No No 100 % 
F-12  16 Folds 3.20 4.3 17 % 100 % 
 
RESULT AND DISCUSSION  
Transdermal drug delivery system is one of the 
promising alternatives to oral dosage forms especially for 
drugs that are subjected to first pass metabolism. 
Evaluation of free patches has proved a popular means of 
assessing the properties of polymeric patches. The use of 
mercury substrate method for the preparation yielded 
transparent, smooth and uniform patches. The drug free 
patches of different polymers were prepared by solvent 
evaporation technique employing mercury as a substrate 
to explore their feasibility for transdermal application. 
The formulations were evaluated (Table-2) for tensile 
strength, WVTR, folding endurance, Water vapor 
transmission rate and percent elongation properties.  
Flatness studies were performed to assess the same. 100 
% flatness of all the formulation indicates no amount of 
constriction in formulated transdermal patches. Thus this 
could better maintain a smooth surface when applied 
onto the skin.  
The folding endurance measures the ability of patch to 
withstand rupture. The patch prepared by 20% 
concentration of plasticizer Group-D (F-10, F-11, F-12) 
having very large folding endurance as compare to the 
films prepared by 10% concentration of plasticizer  
Group-A (F-1, F-2, F-3) with different polymers 
combination (Figure 1). The result of 20% plasticizer 
indicated that the patches would not break and would 
maintain their integrity with general skin folding when 
used.
 
 
Figure 1: Performance of folding endurance test of drug free transdermal patch 
The WVTR was not significantly affected by varying the 
concentration of plasticizer (Di-n-butylphthalate) as 
shown in the table 2. 
When we focus on the tensile strength and percent 
elongation value of the fabricated formulations the height 
of response increases as increases the concentration of 
plasticizer (Di-n-butylphthalate) but when the 
concentration of plasticizer increases 25%, Group-D (F-
10 & F-11) the no any satisfactory result found due to 
soft and sticky film (Figure 2). On 20% concentration of 
plasticizer form stable film (F-7, F-8, F-9).  The 
difference between Group-A and Group-B in percent 
elongation is not very large (10% to 15% only) but at 
same polymer ratio and different plasticizer 
concentration the Group-C (F-7, F-8, F-9) have very high 
percent elongation. 
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Figure 2: Performance of tensile strength and percent elongation test of drug free transdermal patch 
 
CONCLUSION 
Hence from above study it can be concluded that, the 
effect of concentration of plasticizer on the formulation 
is very important for developing a good and stable 
formulation. Here the 20% w/w concentration of Di-n-
butylphthalate was the optimum concentration which 
forms the films with good strength, flexibility and 
appearance. When we increase the concentration it 
effects on the stability of formulation. For further 
developmental studies Di-n-butylphthalate was 
incorporated as a plasticizer at a concentration of 20% 
w/w of polymers. 
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